Does Dr. JOHN BALLERT have financial conflicts of interest?

Dr. JOHN BALLERT (MD) has received a total of $1,253 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $1,253 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JOHN BALLERT?

According to CMS Open Payments data, Dr. JOHN BALLERT received funding from GALDERMA LABORATORIES, L.P ($341), GENZYME CORPORATION ($183), and DEPUY SYNTHES SALES ($164).

Does Dr. JOHN BALLERT receive research grants or speaking fees?

Dr. JOHN BALLERT has received $1,253 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JOHN BALLERT

MDReal-Time Hydrated

Specialty: Otolaryngology, Facial Plastic Surgery

Practice Location: PADUCAH, KY 42003

NPI Number: 1831304088

LIFETIME INDUSTRY VALUE

$1,253

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. BALLERT is a verified Otolaryngology, Facial Plastic Surgery practitioner based in PADUCAH, KY.

Between 2021 and 2024, Dr. BALLERT had an overall industry promotional and research financial footprint of $1,253 as recorded in the federal CMS Open Payments database.

$1,253 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BALLERT's primary funding source is GALDERMA LABORATORIES, L.P, which accounts for $341 (representing 27.2% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GALDERMA LABORATORIES, L.P

Rank 1

$341

27.2%

GENZYME CORPORATION

Rank 2

$183

14.6%

DEPUY SYNTHES SALES

Rank 3

$164

13.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.